Read Financial Articles on Day Trading, Investment, Stock Market, NIFTY, BSE, NSE, Mutual Fund, Commodities and ETF
JACKPOT PACKAGE: Get 95%+ Accuracy in our premium package. Charges only Rs.5000/Month.
To Get Free Trial Just SMS JACKPOT and your Name to 9999961207 or Call Us.
Share Gyan launches new website for COMMODITY TIPS. Register for free trial @ CommodityGyan.in now!


RANBAXY LABORATORIES

Monday, June 7, 2010 1:18 am
admin
COMPANY NAME – RANBAXY  LABORATORIES
RECOMMENDATION – SELL
STOCK CURRENT PRICE – 430
TARGET – 350
COMPANY BASIC INFORMATION
ISIN Id – INE015A01028
BSE Id – 500359
NSE Id – RANBAXY
INDUSTRY – Pharmaceuticals
Market Cap – 18090.84
Book Value – 84.18
EPS (TTM) – 52.81
Price/Book – 5.11
Face Value – 5.00
P/E – 8.14
Div(%) – 10.00%
Industry P/E – 22.54
P/C – 7.63
STOCK PRICE HISTORY (NSE)
All Time High – 1279.40
All Time Low – 133.10
52 Week High – 538.45
52 Week Low – 236.00
DAILY CHART:
Recommendation-
The stock seems to have formed an intermediate top in previous moths and gave a breakout on the downside in the second half of the last month. However, it witnessed a pullback rally on low volumes up to the breakout point and failed to close above it. Also the stock has given a closing below its 200 DMA on Friday’s session. We expect a fresh round of shorts building in the counter from current levels which might put further pressure on it and therefore recommend a Sell on the stock for targets of 350-360 levels within 2-3 months however one should keep a stop above 450 on closing levels on all short positions.
You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Copyright © 2008 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.